Recontact: a survey of current practices and BRCA1/2 testing in Japan

Andorno R. The right not to know: an autonomy based approach. J Med Ethics. 2004;30:435–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Otten E, Plantinga M, Birnie E, Verkerk MA, Lucassen AM, Ranchor AV, et al. Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature. Genet Med. 2015;17:668–78.

Article  CAS  PubMed  Google Scholar 

Carrieri D, Lucassen AM, Clarke AJ, Dheensa S, Doheny S, Turnpenny PD, et al. Recontact in clinical practice: a survey of clinical genetics services in the United Kingdom. Genet Med. 2016;18:876–81.

Article  PubMed  PubMed Central  Google Scholar 

Sirchia F, Carrieri D, Dheensa S, Benjamin C, Kayserili H, Cordier C, et al. Recontacting or not recontacting? A survey of current practices in clinical genetics centres in Europe. Eur J Hum Genet. 2018;26:946–54.

Article  PubMed  PubMed Central  Google Scholar 

Giesbertz NAA, van Harten WH, Bredenoord AL. A duty to recontact in genetics: context matters. Nat Rev Genet. 2019;20:371–2.

Article  CAS  PubMed  Google Scholar 

Mitchell C, Ploem C, Retèl V, Gevers S, Hennekam R. Experts reflecting on the duty to recontact patients and research participants; why professionals should take the lead in developing guidelines. Eur J Med Genet. 2020;63:103642.

Article  PubMed  Google Scholar 

Hirschhorn K, Fleisher LD, Godmilow L, Howell RR, Lebel RR, McCabe ER, et al. Duty to re-contact. Genet Med. 1999;1:171–2.

Article  CAS  PubMed  Google Scholar 

David KL, Best RG, Brenman LM, Bush L, Deignan JL, Flannery D, et al. Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2019;21:769–71.

Article  PubMed  Google Scholar 

Bombard Y, Brothers KB, Fitzgerald-Butt S, Garrison NA, Jamal L, James CA, et al. The responsibility to recontact research participants after reinterpretation of genetic and genomic research results. Am J Hum Genet. 2019;104:578–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carrieri D, Howard HC, Benjamin C, Clarke AJ, Dheensa S, Doheny S, et al. Recontacting patients in clinical genetics services: recommendations of the European Society of Human Genetics. Eur J Hum Genet. 2019;27:169–82.

Article  PubMed  Google Scholar 

Vora BB, Mountain H, Nichols C, Schofield L. Opinions and experiences of recontacting patients: a survey of Australasian genetic health professionals. J Community Genet. 2022;13:193–9.

Article  PubMed  PubMed Central  Google Scholar 

van El CG, Cornel MC, Borry P, Hastings RJ, Fellmann F, Hodgson SV, et al. Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics. Eur J Hum Genet. 2013;21:580–4.

Article  PubMed  PubMed Central  Google Scholar 

The Japanese Association of Medical Sciences. Guidelines for Genetic Tests and Diagnoses in Medical Practice, 2011. https://jams.med.or.jp/guideline/genetics-diagnosis_e.pdf Accessed 29 Apr 2022.

Guidelines for Diagnosis and Treatment of Hereditary Breast and Ovarian Cancer 2021. https://johboc.jp/guidebook_2021/ Accessed 10 Dec 2022.

Actionability Summary Report Japanese Edition. http://www.idenshiiryoubumon.org/actionability_japan/index.html Accessed 29 Apr 2022.

Harrison SM, Rehm HL. Is ‘likely pathogenic’ really 90% likely? Reclassification data in ClinVar. Genome Med. 2019;11:72.

Article  PubMed  PubMed Central  Google Scholar 

Esterling L, Wijayatunge R, Brown K, Morris B, Hughes E, Pruss D, et al. Impact of a cancer gene variant reclassification program over a 20-year period. JCO Precis Oncol. 2020;4:PO.20.00020.

PubMed  PubMed Central  Google Scholar 

Mersch J, Brown N, Pirzadeh-Miller S, Mundt E, Cox HC, Brown K, et al. Prevalence of variant reclassification following hereditary cancer genetic testing. JAMA. 2018;320:1266–74.

Article  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif